Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve (a) early diagnosis and (b) treatment of genetic haemochromatosis.

Genomic testing in the National Health Service in England is provided through the NHS Genomic Medicine Service (GMS) and directed by the National Genomic Test Directory which sets out the eligibility criteria for patients to access testing as well as the genomic targets to be tested.

Genomic testing for haemochromatosis is available through the NHS GMS for people who show unexplained iron overload suggestive of hereditary haemochromatosis. Testing is available for all eligible patients across England and any healthcare professional who suspects their patient may have haemochromatosis can refer their patient for testing via their local NHS Clinical Genomic Service.

Treatment for genetic haemochromatosis is commissioned by local integrated care boards, including venesection, also known as phlebotomy, to remove some blood to reduce blood iron levels. In a small number of cases where regular phlebotomies are not possible, a chelation therapy may be used.